Targeted Oncogene Mutation Detection in Non-small Cell Lung Cancer by Multiplexed Array Mass Spectrometry Genotyping: Results of a Clinical Validation Study
Cancer is the second leading cause of death in New Zealand and despite being the fifth most commonly diagnosed cancer, lung cancers are the leading cause of cancer related deaths and one of the major health issues affecting New Zealand (Ministry of Health, 2016). The relatively recent discovery of c...
Main Author: | Shepherd, Phillip (Author) |
---|---|
Other Authors: | McKeage, Mark (Contributor), Li, Yan (Contributor) |
Format: | Others |
Published: |
Auckland University of Technology,
2017-10-29T22:04:35Z.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Epigenetic Regulation of Mitochondrial Quality Control Genes in Multiple Myeloma: A Sequenom MassARRAY Pilot Investigation on HMCLs
by: Patrizia D’Aquila, et al.
Published: (2021-03-01) -
Mutation profiling in gallbladder cancer in Indian population
by: Niraj Kumari, et al.
Published: (2014-01-01) -
Central nervous system progression in advanced non–small cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotinib: a comparative study
by: Meng-Xia Li, et al.
Published: (2017-04-01) -
Evaluation of current methods to detect the mutations of epidermal growth factor receptor in non-small cell lung cancer patients
by: Obradovic Jasmina, et al.
Published: (2012-12-01) -
Oncogenic Fusions May Be Frequently Present at Resistance of EGFR Tyrosine Kinase Inhibitors in Patients With NSCLC: A Brief Report
by: Diego Enrico, MD, et al.
Published: (2020-06-01)